Life sciences manufacturing – Cognizant to acquire Zenith Technologies

    Digital transformation in the life sciences industry enables more flexible and efficient manufacturing facilities to bring new treatments to market faster according to Zenith Technologies CEO Joe Haugh as Cognizant acquires the company to strengthen its life sciences business unit and industrial transformation expertise.
    Cognizant CEO Brian Humphries - the acquisition of Zenith Technologies is the first of Cognizant since he became CEO
    Cognizant CEO Brian Humphries – the acquisition of Zenith Technologies is the first acquisition Cognizant makes since he became CEO early April 2019

    In a move to strengthen its Industry 4.0 offering and life sciences activities, Cognizant announced it is to acquire Zenith Technologies, an automation expert specialized in the pharma and biotech industry.

    Zenith Technologies was founded in 1998 in Ireland and offers manufacturing software systems securing the supply of vital treatments to patients across the globe. On top of the implementation and support of automation, manufacturing executing systems (MES) and other solutions to enhance operational efficiency and regulatory compliance in drug and medical device production manufacturing plants, the company also offers consultancy and incident management.

    Cognizant CEO Brian Humphries states that the acquisition of Zenith Technologies expands Cognizant’s IoT portfolio and extend its life sciences domain expertise by becoming a single-source provider of end-to-end smart factory capabilities.

    Converging industrial and operational technologies in life sciences manufacturing operations

    Emphasizing that Industry 4.0 solutions, encompassing IoT, automation and analytics are a strategic focus area for Cognizant, Humphries points out that the acquisition enables to help clients realize IT and OT convergence in their manufacturing operations, and advance the development of life-saving drugs, biologics, specialized pharmaceuticals and medical devices.

    Financial details were not disclosed. The acquisition of Zenith Technologies that operates on five continents with 16 locations and works with nine of the ten largest biopharmaceutical manufacturers is expected to close in the fourth quarter of 2019. The acquisition is Cognizant’s first since Brian Humphries became CEO in April, replacing Francisco D’Souza, and the company slashed its revenue forecast for 2019, whereby ongoing mergers among some of its healthcare clients were cited as one reason.

    Zenith Technologies, named “Pharma Supplier of the Year” at the 2018 Pharma Industry Awards, employs over 800 people that are becoming part of the Life Sciences business unit of digital transformation technology and services provider Cognizant.

    Digital transformation in life sciences as production systems and processes becoming more complex

    The life sciences industry is embracing digital transformation says Zenith Technologies CEO Joe Haugh.

    It’s clear that big data and analytics are key here as well. IDC found that the main technologies for investment in selected life sciences digital transformation use cases included cloud, security, analytics, AI, mobility, social and blockchain.

    Joe Haugh CEO of Zenith Technologies - source
    Joe Haugh CEO of Zenith Technologies: “Our combined business will drive process excellence through tighter integration of manufacturing processes and systems, the efficient harnessing of information and analytics across the manufacturing value chain, and the adoption of IoT technologies delivering manufacturing 4.0.”

    Priorities included smart laboratory programs, R&D collaborative infrastructure and clinical data transformation. And of course, patient engagement is import as well. Interconnected “smart factories” have become a strategic priority for the life sciences industry, with production systems and processes becoming more complex because of research advances and increased demand for large-molecule biologics, Cognizant states.

    The combined Cognizant-Zenith Technologies expertise will deliver a range of industrial transformation capabilities, ranging from factory design consultation, machine sensor and controller instrumentation, supervisory control, and data acquisition, to manufacturing execution systems, batch automation, enterprise resource planning (ERP) integration and managed services.

    Joe Haugh says that digital transformation in the life science industry enables more flexible and efficient manufacturing facilities to bring new treatments to market faster. Haugh adds: “Our combined business will drive process excellence through tighter integration of manufacturing processes and systems, the efficient harnessing of information and analytics across the manufacturing value chain, and the adoption of IoT technologies delivering manufacturing 4.0. Together, we are well-positioned to help clients more efficiently produce the life-changing medicines and medical devices for patients who need them most”.

    More: Cognizant life sciences solutions.

    All pictures belong to their respective owners.